Cited by 2,287Pregnancy and preeclampsia studiesNeurological Complications and SyndromesNeonatal and fetal brain pathology

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Open access

Rolnik, Daniel L., Wright, David, Poon, Liona C., O’Gorman, Neil, Syngelaki, Argyro, de Paco Matallana, Catalina, Akolekar, Ranjit, Cicero, Simona, Janga, Deepa, Singh, Mandeep, Molina, Francisca S., Persico, Nicola, Jani, Jacques C., Plasencia, Walter, Papaioannou, George, Tenenbaum-Gavish, Kinneret, Meiri, Hamutal, Gizurarson, Sveinbjorn, Maclagan, Kate, Nicolaides, Kypros H.·2017·New England Journal of Medicine

DOI 10.1056/nejmoa1704559

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Preterm preeclampsia is an important cause of maternal and perinatal death and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia. METHODS: In this multicenter, double-blind, placebo-controlled trial, we randomly assigned 1776 women with singleton pregnancies who were at high risk for preterm preeclampsia to receive aspirin, at a dose of 150 mg per day, or placebo from 11 to 14 weeks of gestation until 36 weeks of gestation. The primary outcome was delivery with preeclampsia before 37 weeks of gestation. The analysis was performed according to the intention-to-treat principle. RESULTS: A total of 152 women withdrew consent during the trial, and 4 were lost to follow up, which left 798 participants in the aspirin group and 822 in the placebo group. Preterm preeclampsia occurred in 13 participants (1.6%) in the aspirin group, as compared with 35 (4.3%) in the placebo group (odds ratio in the aspirin group, 0.38; 95% confidence interval, 0.20 to 0.74; P=0.004). Results were materially unchanged in a sensitivity analysis that took into account participants who had withdrawn or were lost to follow-up. Adherence was good, with a reported intake of 85% or more of the required number of tablets in 79.9% of the participants. There were no significant between-group differences in the incidence of neonatal adverse outcomes or other adverse events. CONCLUSIONS: Treatment with low-dose aspirin in women at high risk for preterm preeclampsia resulted in a lower incidence of this diagnosis than placebo. (Funded by the European Union Seventh Framework Program and the Fetal Medicine Foundation; EudraCT number, 2013-003778-29 ; Current Controlled Trials number, ISRCTN13633058 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1704559

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)
Brown, M. A., Lindheimer, M. D., de Swiet, M., Assche, A. V., & Moutquin, J. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS
Robinson, H. P., & Fleming, J. E. E. (1975) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1975.tb00710.x · Cited by 1,413
The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
Brown, M. A., Lindheimer, M. D., de SWIET, M., et al. (2001) · Hypertension in Pregnancy · doi:10.3109/10641950109152635 · Cited by 1,369
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy
Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J., & Giguère, Y. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e9322a · Cited by 1,112
Long term mortality of mothers and fathers after pre-eclampsia: population based cohort studyPre-eclampsia and cardiovascular disease later in life: who is at risk?
Irgens, H. U., Roberts, J. M., Reisæter, L., Irgens, L. M., & Lie, R. T. (2001) · BMJ · doi:10.1136/bmj.323.7323.1213 · Cited by 1,040
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Askie, L. M., Duley, L., Henderson-Smart, D. J., & Stewart, L. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60712-0 · Cited by 1,025
Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease
Lisonkova, S., & Joseph, K. S. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.08.019 · Cited by 926
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679
Self-citation

Show all 24 references

Research works printed but not linked: 2

National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: RCOG Press, 2010.
Van Buuren S, 2011, J Stat Softw, 45, 1

Sorted by citations

Items 601–700 of 1,002

Risk for Cesarean section in women of advanced maternal age under the changed reproductive policy in China: A cohort study in a tertiary hospital in southwestern China
Xie, M., Lao, T. T.-H., Du, M., Sun, Q., Qu, Z., Ma, J., Song, X., Wang, M.-F., Xu, D., & Ma, R. (2019) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14048 · Cited by 23
Early and late onset pre-eclampsia and small for gestational age risk in subsequent pregnancies
Bernardes, T. P., Mol, B. W., Ravelli, A. C. J., van den Berg, P., Boezen, H. M., & Groen, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230483 · Cited by 23
Second‐ and third‐trimester serum levels of growth‐differentiation factor‐15 in prediction of pre‐eclampsia
Wertaschnigg, D., Rolnik, D. L., Nie, G., Teoh, S. S. Y., Syngelaki, A., Costa, F. D. S., & Nicolaides, K. H. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.22070 · Cited by 23
Self-citation
Deep Sequencing Identified Dysregulated Circulating MicroRNAs in Late Onset Preeclampsia
Mavreli, D., Lykoudi, A., Lambrou, G. Ι., Papaioannou, G., VRACHNIS, N., Kalantaridou, S., Papantoniou, N., & Kοlialexi, A. (2020) · In Vivo · doi:10.21873/invivo.12044 · Cited by 23
Self-citation
Chronic Kidney Disease and Pregnancy
Reynolds, M. L., & Herrera, C. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2020.04.003 · Cited by 24
Effect of routine first‐trimester combined screening for pre‐eclampsia on small‐for‐gestational‐age birth: secondary interrupted time series analysis
Guy, G. P., Leslie, K., Gomez, D. D., Forenc, K. M., Buck, E., Bhide, A., & Thilaganathan, B. (2021) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23741 · Cited by 23
A glimpse into the future of systemic lupus erythematosus
Aringer, M., Alarcón-Riquelme, M. E., Clowse, M. E. B., Pons-Estel, G. J., Vital, E. M. J., & Dall’Era, M. (2022) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x221086719 · Cited by 23
Classification of preeclampsia according to molecular clusters with the goal of achieving personalized prevention
Than, N. G., Romero, R. J., Posta, M., Györffy, D., Szalai, G., Rossi, S. W., Szilágyi, A., Hupuczi, P., Nagy, S., Török, O., et al. (2023) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2023.104172 · Cited by 23
Navigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications
Świercz, G., Zmelonek-Znamirowska, A., Szwabowicz, K., Armańska, J., Detka, K., Młodawska, M., & Młodawski, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071982 · Cited by 22
Aspirin 162 mg vs 81 mg for preeclampsia prophylaxis in high-risk obese individuals: a comparative effectiveness open-label randomized trial (ASPREO)
Amro, F. H., Blackwell, S. C., Pedroza, C., Backley, S., Bitar, G., Daye, N., Bartal, M. F., Chauhan, S. P., & Sibai, B. M. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.06.038 · Cited by 22
Placental thromboinflammation impairs embryonic survival by reducing placental thrombomodulin expression
Kohli, S., Singh, K. K., Gupta, A., Markmeyer, P., Lochmann, F., Gupta, D., Rana, R., Elwakiel, A., Huebner, H., Ruebner, M., et al. (2020) · Blood · doi:10.1182/blood.2020005225 · Cited by 22
Preeclampsia: state of art and future perspectives. A special focus on possible preventions
Kahramanoğlu, Ö., Schiattarella, A., Demirci, O., Sisti, G., Ammaturo, F. P., Trotta, C., Ferrari, F. G., & Rapisarda, A. M. C. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2048810 · Cited by 23
Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events
Smith‐Jackson, K., & Harrison, R. A. (2022) · Immunological Reviews · doi:10.1111/imr.13169 · Cited by 22
The use of artificial intelligence and machine learning methods in early pregnancy pre-eclampsia screening: A systematic review protocol
Hedley, P. L., Hagen, C. M., Wilstrup, C., & Christiansen, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0272465 · Cited by 22
Adverse obstetric and perinatal outcomes of patients with history of recurrent miscarriage: a retrospective cohort study
Zhang, J., Liu, X., Rao, L., Ma, R., Wu, W., Chen, C., & Lin, Y. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.04.028 · Cited by 22
Exosomal small RNA profiling in first-trimester maternal blood explores early molecular pathways of preterm preeclampsia
Gál, L., Fóthi, Á., Orosz, G., Nagy, S., Than, N. G., & Orbán, T. I. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1321191 · Cited by 22
Aspirin for preeclampsia prevention in low- and middle-income countries: mind the gaps
Kupka, E., Roberts, J. M., Mahdy, Z. A., Escudero, C., Bergman, L., & Oliveira, L. G. (2024) · AJOG Global Reports · doi:10.1016/j.xagr.2024.100352 · Cited by 22
Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age
Madar-Shapiro, L., Karady, I., Trahtenherts, A., Syngelaki, A., Akolekar, R., Poon, L. C., Cohen, R., Sharabi‐Nov, A., Huppertz, B., Sammar, M., et al. (2017) · Fetal Diagnosis and Therapy · doi:10.1159/000477933 · Cited by 22
Self-citation
First trimester screening for pre‐eclampsia in Chinese pregnancies: case–control study
Cheng, Y., Leung, T., Law, L. W., Ting, Y., Law, K., & Sahota, D. S. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14970 · Cited by 22
First-Trimester Uterine Artery Doppler for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndrome Study
Demers, S., Boutin, A., Gasse, C., Drouin, O., Girard, M., & Bujold, E. (2018) · American Journal of Perinatology · doi:10.1055/s-0038-1675209 · Cited by 22
Low-dose aspirin protective effects are correlated with deregulation of HNF factor expression in the preeclamptic placentas from mice and humans
Ducat, A., Vargas, A., Doridot, L., Bagattin, A., Lerner, J., Vilotte, J.-L., Buffat, C., Pontoglio, M., Miralles, F., & Vaiman, D. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0170-x · Cited by 22
Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year
Lourenço, I. O., Gomes, H., Ribeiro, J., Caeiro, F., Rocha, P., & Francisco, C. (2020) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0040-1712124 · Cited by 22
Role of the Macrophage Migration Inhibitory Factor in the Pathophysiology of Pre-Eclampsia
Todros, T., Paulesu, L. R., Cardaropoli, S., Rolfo, A., Masturzo, B., Ermini, L., Romagnoli, R., & Ietta, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041823 · Cited by 22
Hypertension in pregnancy
Mortimer, R. M., & McCarthy, F. P. (2018) · Obstetrics Gynaecology & Reproductive Medicine · doi:10.1016/j.ogrm.2018.03.003 · Cited by 22
Maternal cardiac function in women at high risk for pre‐eclampsia treated with 150 mg aspirin or placebo: an observational study
Ling, H. Z., Jara, P. G., Bisquera, A., Poon, L. C., Nicolaides, K. H., & Kametas, N. A. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16193 · Cited by 21
Self-citation
Fetal Growth Restriction – Diagnostic Work-up, Management and Delivery
Schlembach, D. (2020) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1232-1418 · Cited by 21
Acute systemic inhibition of inflammation augments endothelium-dependent dilation in women with a history of preeclamptic pregnancy
Stanhewicz, A. E., Dillon, G. A., Serviente, C. F., & Alexander, L. M. (2021) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.12.010 · Cited by 21
Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage
Colafella, K. M. M., van Dorst, D. C. H., Neuman, R. I., van Doorn, L., Neves, K. B., Montezano, A. C. I., Garrelds, I. M., van Veghel, R., VRIES, R. D., Uijl, E., et al. (2022) · Clinical Science · doi:10.1042/cs20220182 · Cited by 22
Increased NOS coupling by the metabolite tetrahydrobiopterin (BH4) reduces preeclampsia/IUGR consequences
Châtre, L., Ducat, A., Spradley, F. T., Palei, A. C., Chéreau, C., Couderc, B., Thomas, K. C., Wilson, A. R., Amaral, L. M., Gaillard, I., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102406 · Cited by 21
Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial
Diguisto, C., Gouge, A. L., Marchand, M.-S., Mégier, P., Ville, Y. G., Haddad, G., Winer, N., Arthuis, C., Doret, M., Debarge, V., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275129 · Cited by 23
Hipertensión y embarazo: revisión de la literatura
Luna, S. D., & Martinovic, T. C. (2023) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2023.01.006 · Cited by 21
Maternal blood‐pressure trends throughout pregnancy and development of pre‐eclampsia in women receiving first‐trimester aspirin prophylaxis
Baschat, A., Dewberry, D., Seravalli, V., Miller, J. L., Block‐Abraham, D., & Blitzer, M. G. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.18992 · Cited by 21
Pregnancy in systemic sclerosis
Betelli, M., Breda, S., Ramoni, V. L., Parisi, F., Rampello, S., Limonta, M., Meroni, M., & Brucato, A. L. (2018) · Journal of Scleroderma and Related Disorders · doi:10.1177/2397198317747440 · Cited by 21
Magnesium Supplementation and Blood Pressure in Pregnancy: A Double-Blind Randomized Multicenter Study
Bullarbo, M., Mattson, H., Broman, A., Ödman, N., & Nielsen, T. F. (2018) · Journal of Pregnancy · doi:10.1155/2018/4843159 · Cited by 21
Evidence-Based Prevention of Preeclampsia: Commonly Asked Questions in Clinical Practice
Wertaschnigg, D., Reddy, M., Mol, B. W., Costa, F. D. S., & Rolnik, D. L. (2019) · Journal of Pregnancy · doi:10.1155/2019/2675101 · Cited by 21
Self-citation
Pilot Interventional Study Comparing Fetomaternal Outcomes of 150 mg Versus 75 mg Aspirin Starting Between 11 and 14 Weeks of Pregnancy in Patients with High Risk of Preeclampsia: A Randomized Control Trial
Kumar, N., Das, V., Ak, A., Pandey, A., Agrawal, S., & Singh, A. (2019) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-019-01277-5 · Cited by 21
Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study
Simon, E. D. S., Herraı̀z, I., Villalaín, C., Gómez‐Arriaga, P. I., Quezada, M. S., López-Jiménez, E. A., & Galindo, A. (2020) · Pregnancy Hypertension · doi:10.1016/j.preghy.2020.03.002 · Cited by 21
Pravastatin for preeclampsia: From animal to human
Kumasawa, K., Iriyama, T., Nagamatsu, T., Osuga, Y., & Fujii, T. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14295 · Cited by 21
Preterm parturition and pre‐eclampsia: The confluence of two great gestational syndromes
Jayaram, A., Collier, C., & Martin, J. N., Jr. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13173 · Cited by 21
Long noncoding RNA SNHG12 promotes the proliferation, migration, and invasion of trophoblast cells by regulating the epithelial–mesenchymal transition and cell cycle
Zhou, F., Sun, Y., Chi, Z., Gao, Q., & Wang, H. (2020) · Journal of International Medical Research · doi:10.1177/0300060520922339 · Cited by 21
Improving Utilization of Aspirin for Prevention of Preeclampsia in a High-Risk Urban Cohort: A Prospective Cohort Study
Boelig, R. C., Wanees, M., Zhan, T., Berghella, V., & Roman, A. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1718580 · Cited by 21
Preeclampsia pathogenesis and prediction - where are we now: the focus on the role of galectins and miRNAs
Orlić, N. K., & Joksić, I. (2025) · Hypertension in Pregnancy · doi:10.1080/10641955.2025.2470626 · Cited by 23
Temporal validation of machine learning models for pre-eclampsia prediction using routinely collected maternal characteristics: A validation study
Tiruneh, S. A., Rolnik, D. L., Teede, H. J., & Enticott, J. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110183 · Cited by 21
Self-citation
Barriers to progress in pregnancy research: How can we break through?
Stock, S. J., & Aiken, C. (2023) · Science · doi:10.1126/science.adf9347 · Cited by 20
Vaginal micronised progesterone for the prevention of hypertensive disorders of pregnancy: A systematic review and meta‐analysis
Melo, P., Devall, A., Shennan, A. H., Vatish, M., Becker, C. M., Granne, I., Papageorghiou, A. T., Mol, B. W., & Coomarasamy, A. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17705 · Cited by 20
II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment
dos Reis-Neto, E. T., Seguro, L. P. C., Sato, E. I., Borba, E. F., Klumb, E. M., Costallat, L. T. L., Medeiros, M. M. D. C., Bonfá, E., Araújo, N. C., Appenzeller, S., et al. (2024) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-024-00386-8 · Cited by 21
A comprehensive review of the roles of T-cell immunity in preeclampsia
Xu, P., Oluchi-Amaka, I. C., Kwak-Kim, J. Y.-H., & Yang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1476123 · Cited by 20
Does Low PAPP-A Predict Adverse Placenta-Mediated Outcomes in a Low-Risk Nulliparous Population? the Great Obstetrical Syndromes (GOS) Study
Boutin, A., Gasse, C., Demers, S., Blanchet, G., Giguère, Y., & Bujold, E. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.08.047 · Cited by 20
An updated view on the origin and use of angiogenic biomarkers for preeclampsia
Huppertz, B. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1546579 · Cited by 20
Resistance of aspirin during and after pregnancy: A longitudinal cohort study
de Weg, J. M. B., Abheiden, C. N. H., Fuijkschot, W. W., Harmsze, A. M., de Boer, M. A., Thijs, A., & de Vries, J. I. P. (2019) · Pregnancy Hypertension · doi:10.1016/j.preghy.2019.11.008 · Cited by 20
First Trimester Protein Biomarkers for Risk of Spontaneous Preterm Birth: Identifying a Critical Need for More Rigorous Approaches to Biomarker Identification and Validation
D’Silva, A., Hyett, J. A., & Coorssen, J. R. (2020) · Fetal Diagnosis and Therapy · doi:10.1159/000504975 · Cited by 20
Association between serum copeptin levels and preeclampsia risk: A meta-analysis
Bellos, I., Pergialiotis, V., Papapanagiotou, A., Loutradis, D., & Daskalakis, G. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.04.051 · Cited by 20
Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin
Walsh, S. W., Reep, D., Alam, S. M. K., Washington, S. L., Dulaimi, M. A., Lee, S. M., Springel, E. H., Strauss, J. F., Stephenson, D., & Chalfant, C. E. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00234-2 · Cited by 20
Potential Protein Biomarkers for Preeclampsia
He, A., Zhou, Y., Wei, Y., & Li, R. (2020) · Cureus · doi:10.7759/cureus.8925 · Cited by 20
Placental abruption in each hypertensive disorders of pregnancy phenotype: a retrospective cohort study using a national inpatient database in Japan
Naruse, K., Shigemi, D., Hashiguchi, M., Imamura, M., Yasunaga, H., Arai, T., Yasuhi, I., Ozaki, Y., Sakajo, A., Tajima, A., et al. (2020) · Hypertension Research · doi:10.1038/s41440-020-00537-6 · Cited by 20
Missed opportunities to prevent cardiovascular disease in women with prior preeclampsia
Brener, A., Lewnard, I., Mackinnon, J., Jones, C., Lohr, N. L., Konda, S., McIntosh, J. J., & Kulinski, J. P. (2020) · BMC Women s Health · doi:10.1186/s12905-020-01074-7 · Cited by 22
Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia
Richards, C., Sesperez, K., Chhor, M., Ghorbanpour, S. M., Rennie, C., Ming, C. L. C., Evenhuis, C. R., Nikolic, V. N., Orlić, N. K., Miković, Ž., et al. (2021) · Biology of Sex Differences · doi:10.1186/s13293-021-00376-1 · Cited by 20
Prospective Evaluation of International Prediction of Pregnancy Complications Collaborative Network Models for Prediction of Preeclampsia: Role of Serum sFlt-1 at 11–13 Weeks’ Gestation
Chaiyasit, N., Sahota, D. S., Ma, R., Choolani, M., Wataganara, T., Sim, W. S., Chaemsaithong, P., Wah, Y. M. I., Hui, S. Y. A., & Poon, L. C. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.18021 · Cited by 20
Self-citation
How important is aspirin adherence when evaluating effectiveness of low-dose aspirin?
Navaratnam, K., Alfirević, Ž., Pirmohamed, M., & Alfirevic, A. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.10.004 · Cited by 20
Cancer in pregnancy: FIGO Best practice advice and narrative review
Nanda, S., Nana, M., Nguyen‐Hoang, L., Adam, S., McAuliffe, F. M., Bergman, L., Wilailak, S., McNally, O., Maxwell, C. V., Purandare, N. C., et al. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70258 · Cited by 19
Self-citation
Scheduled birth at term for the prevention of pre-eclampsia (PREVENT-PE): an open-label randomised controlled trial
Goadsby, J., Syngelaki, A., Magee, L. A., von Dadelszen, P., Akolekar, R., Webster, S., Wright, A., Wright, D. E., & Nicolaides, K. H. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01207-3 · Cited by 19
Self-citation
Reasons for accepting or declining participation in the ASPRE trial: A qualitative study with women at high risk of preterm pre‐eclampsia
Nikčević, A. V., Dodd, Z., Prior, J., O’Gorman, N., Poon, L. C., & Nicolaides, K. H. (2019) · Prenatal Diagnosis · doi:10.1002/pd.5554 · Cited by 19
Self-citation
Prediction of pre-eclampsia
Giannakou, K. (2021) · Obstetric Medicine · doi:10.1177/1753495x20984015 · Cited by 19
Animal Models of Cardiovascular Complications of Pregnancy
Arany, Z. P., Hilfiker‐Kleiner, D., & Karumanchi, S. A. (2022) · Circulation Research · doi:10.1161/circresaha.122.320395 · Cited by 19
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study
Tani, C., Zucchi, D., Haase, I., Gerosa, M., Larosa, M., Cavagna, L., Bortoluzzi, A., Crisafulli, F., Mücke, J., Strigini, F. A. L., et al. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2022-000714 · Cited by 19
Low-dose aspirin inhibits trophoblast cell apoptosis by activating the CREB/Bcl-2 pathway in pre-eclampsia
Guo, K.-M., Li, W., Wang, Z.-H., He, L., Feng, Y., & Liu, H. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2092814 · Cited by 19
Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/050, May 2022)
Tóth, B., Bohlmann, M. K., Hancke, K., Kuon, R., Nawroth, F., von Otte, S., Rogenhofer, N. N., Rudnik‐Schöneborn, S., Schleußner, E., Tempfer, C. M., et al. (2022) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1895-9940 · Cited by 22
Hypertension across a Woman's lifespan
D’Ignazio, T., Grand’Maison, S., Bérubé, L., Forcillo, J., & Pacheco, C. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.11.006 · Cited by 19
First-trimester preterm preeclampsia prediction with metabolite biomarkers: differential prediction according to maternal body mass index
Tuytten, R., Syngelaki, A., Thomas, G. R., Panigassi, A. P., Brown, L. W., Ortea, P., & Nicolaides, K. H. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.12.012 · Cited by 22
Self-citation
Prediction of hypertensive disorders after screening at 36 weeks' gestation: comparison of angiogenic markers with competing‐risks model
Schiattarella, A., Magee, L. A., Wright, A., Syngelaki, A., Akolekar, R., von Dadelszen, P., & Nicolaides, K. H. (2023) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26291 · Cited by 19
Self-citation
Efficacy and Safety of Aspirin 162 mg for Preeclampsia Prophylaxis in High-Risk Patients
Ayyash, M. K., Goyert, G. L., Garcia, R., Khangura, R. K., Pitts, D., Jacobsen, G., & Shaman, M. (2023) · American Journal of Perinatology · doi:10.1055/s-0043-1771260 · Cited by 19
LMWH prevents thromboinflammation in the placenta via HBEGF-AKT signaling
Singh, K. K., Gupta, A., Forstner, D., Guettler, J., Ahrens, M. S., Sheeja, A. P., Fatima, S., Shamkeeva, S., Lia, M., Dathan‐Stumpf, A., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011895 · Cited by 19
Socioeconomic and ethnic disparities in preterm births in an English maternity setting: a population-based study of 1.3 million births
Kayode, G. A., Howell, A., Burden, C., Margelyte, R., Cheng, V. C., Viner, M., Sandall, J., Carter, J., Brigante, L., Winter, C., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03493-x · Cited by 19
Impact of early supplementation with low-dose aspirin on functional first trimester parameters in low-risk pregnancies
Zvanca, M. E., Boț, M., Radu, D., Radu, N., & Petca, A. T. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1387532 · Cited by 19
Chronic hypertension: effect of blood pressure control on pregnancy outcome
Panaitescu, A. M., Roberge, S., & Nicolaides, K. H. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1390742 · Cited by 19
Self-citation
Antiphospholipid syndrome in obstetrics
Kemp, M., & Thomas, W. (2018) · Lupus · doi:10.1177/0961203318801664 · Cited by 19
White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes
Vestgaard, M. J., Ásbjörnsdóttir, B., Ringholm, L., Andersen, L. L. T., Jensen, D. M., Damm, P., & Mathiesen, E. R. (2019) · Diabetologia · doi:10.1007/s00125-019-05002-9 · Cited by 19
Low molecular weight heparin promotes transcription and release of placental growth factor from endothelial cells
McLaughlin, K., Nadeem, L., Wat, J. M. W., Baczyk, D., Lye, S. J., & Kingdom, J. C. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00109.2020 · Cited by 19
First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases
Hu, J., Zhang, J., He, G., Zhu, S., Tang, X., Su, J., Li, Q., Kong, Y., & Zhu, B. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-2789-2 · Cited by 19
Diagnostic Performance of First Trimester Screening of Preeclampsia Based on Uterine Artery Pulsatility Index and Maternal Risk Factors in Routine Clinical Use
Mönckeberg, M., Arias, V., Fuenzalida, R., Álvarez, S., Toro, V., Calvo, A., Kusanovic, J. P., Monteiro, L. J., Manuel Schepeler, S., Nien, J. K., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10040182 · Cited by 19
Stillbirth at term: Does size really matter?
Coutinho, C. M., Melchiorre, K., & Thilaganathan, B. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13229 · Cited by 19
Pregnancy hypertension diagnosis and care in COVID‐19 era and beyond
Magee, L. A., Khalil, A. A., & von Dadelszen, P. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.22115 · Cited by 19
Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial
Llurba, E., Bella, M., Burgos, J., Mazarico, E., Gómez‐Roig, M. D., de Diego, R., Martínez‐Astorquiza, T., Alijotas‐Reig, J., Sánchez‐Durán, M. Á., Sánchez, O., et al. (2020) · Fetal Diagnosis and Therapy · doi:10.1159/000509662 · Cited by 19
Design of the Pregnancy REmote MOnitoring II study (PREMOM II): a multicenter, randomized controlled trial of remote monitoring for gestational hypertensive disorders
Lanssens, D., Thijs, I. M. V., Gyselaers, W., Gyselaers, W., Thijs, I. M. V., Lanssens, D., de Jonge, E. T., Holsbeke, C. V., Mesens, T., Jacquemyn, Y., et al. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03291-2 · Cited by 19
Incidence and Clinical Risk Factors for Preeclampsia and Its Subtypes: A Population-Based Study in Beijing, China
Lin, L., Huai, J., Su, R., Wang, C., Li, X., & Yang, H. (2021) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000099 · Cited by 19
Maternal Immune System and State of Inflammation Dictate the Fate and Severity of Disease in Preeclampsia
Zhao, X., Chen, S., Zhao, C., & Xia, F. (2021) · Journal of Immunology Research · doi:10.1155/2021/9947884 · Cited by 19
Revised competing‐risks model in screening for pre‐eclampsia in twin pregnancy by maternal characteristics and medical history
Benkő, Z., Chaveeva, P., Matallana, C. D. P., Zingler, E., Wright, D. E., & Nicolaides, K. H. (2019) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20411 · Cited by 19
Self-citation
Barriers and facilitators of adherence to low-dose aspirin during pregnancy: A co-produced systematic review and COM-B framework synthesis of qualitative evidence
Vinogradov, R., Holden, E., Patel, M., Grigg, R., Errington, L., Araújo‐Soares, V., & Rankin, J. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302720 · Cited by 21
Hypertensive Pregnancy Disorder, an Under-Recognized Women Specific Risk Factor for Heart Failure?
Ghossein‐Doha, C., Thilaganathan, B., Vaught, A. “. J., Briller, J. E., & Roos‐Hesselink, J. W. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3520 · Cited by 18
Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt1): powerful new tools to guide obstetric and medical care in pregnancy
Gladstone, R. A., Snelgrove, J. W., McLaughlin, K., Hobson, S. R., Windrim, R. C., Melamed, N., Hladunewich, M., Drewlo, S., & Kingdom, J. C. (2025) · Obstetric Medicine · doi:10.1177/1753495x251327462 · Cited by 18
Prevention of Pre-Eclampsia: Modern Strategies and the Role of Early Screening
Alipova, G., Ablakimova, N., Tussupkaliyeva, K., Bermagambetova, S., Космуратова, Ш. Б., Karimsakova, B., Gaiday, A. N., Gaiday, A., Dinets, A., & Tussupkaliyev, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092970 · Cited by 21
FIGO guideline on liver disease and pregnancy
Nana, M., Medina, V. P., Maxwell, C. V., McCormick, C. A., Taliani, G., Beuers, U. H., Money, D., Jacobsson, B., Kapur, A., Beyuo, T. K., et al. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70161 · Cited by 19
Self-citation
Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women
Keikkala, E., Forstén, J., Ritvos, O., Stenman, U., Kajantie, E., Hämäläinen, E. K., Räikkönen, K., Villa, P., & Laivuori, H. M. (2021) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.05.024 · Cited by 18
Pravastatin is useful for prevention of recurrent severe placenta-mediated complications – a pilot study
Kupferminc, M. J., Kliger, C., Rimon, E., Ascher-Landsberg, J., Skornick‐Rapaport, A., Gamzu, R., & Yogev, Y. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1940940 · Cited by 18
Ultrasound estimated subcutaneous and visceral adipose tissue thicknesses and risk of pre-eclampsia
Maack, H. P., Poromaa, I. S., Lindström, L., Mulic‐Lutvica, A., Junus, K., & Wikström, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-02208-z · Cited by 18
Reducing Perinatal Mortality in India: Two-Years Results of the IRIA Fetal Radiology Samrakshan Program
Choorakuttil, R. M., Rajalingam, B., Satarkar, S. R., Sharma, L. K., Gupta, A., Baghel, A., Jain, N., Devarajan, P., Shenoy, R., Senthilvel, K., et al. (2022) · Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · doi:10.1055/s-0041-1741087 · Cited by 18
Hypertensive disorders of pregnancy and neonatal outcomes in twin vs. singleton pregnancies after assisted reproductive technology
Liu, T., Gao, R., Liu, Y., Zhao, K., Su, X., Wong, H. C., Li, L., Xie, B., Huang, Y., Qiu, C., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.839882 · Cited by 18
Reproductive health in Turner syndrome: A narrative review
Whigham, C., Vollenhoven, B. J., & Vincent, A. J. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6261 · Cited by 18
Clinical practice guidelines on the use of aspirin in pregnancy: Systematic review
Girolamo, R. D., Alameddine, S., Khalil, A. A., Santilli, F., Rizzo, G., Maruotti, G. M., Liberati, M., & D’Antonio, F. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.12.032 · Cited by 18
Hypertension in Pregnancy: What We Now Know
Gupta, S., Petras, L., Tufail, M. U., Salazar, J. D. R., & Jim, B. (2022) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000857 · Cited by 18

Authors: Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., Molina, F. S., Persico, N., Jani, J. C., Plasencia, W., Papaioannou, G., Tenenbaum-Gavish, K., Meiri, H., Gizurarson, S., Maclagan, K., & Nicolaides, K. H.
Affiliations: Université Libre de Bruxelles (BE)
King's College Hospital (GB)
ORCID: Rolnik, Daniel L.
Wright, David
Poon, Liona C.
O’Gorman, Neil
Syngelaki, Argyro
Akolekar, Ranjit
Singh, Mandeep
Molina, Francisca S.
Persico, Nicola
Jani, Jacques C.
Plasencia, Walter
Papaioannou, George
Meiri, Hamutal
Maclagan, Kate
Nicolaides, Kypros H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2017-08-17
Volume: 377
Issue: 7
Pages: 613-622
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1704559
OpenAlex: W2730504020
Cited by: 2,287
References: 24
Citations by year: 2026: 252 · 2025: 277 · 2024: 231 · 2023: 274 · 2022: 257 · 2021: 249 · 2020: 265 · 2019: 212 · 2018: 196 · 2017: 69
FWCI: 238.94
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (publishedVersion, other-oa)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
Funders: Imperial College London
Imperial College Healthcare NHS Trust
University College London
European Commission (FP7-HEALTH-2013INNOVATION, 601852, HEALTH-2013)
Fetal Medicine Foundation
FP7 Health (601852)
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
Keywords: low-dose aspirin, preterm preeclampsia, high-risk pregnancy, preeclampsia prevention, singleton pregnancy, drug safety in pregnancy, adverse neonatal outcomes
MeSH terms: Adult, Aspirin, Double-Blind Method, Female, Humans, Infant, Newborn, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Risk, Incidence, Kaplan-Meier Estimate, Intention to Treat Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks